Miyazaki, Hironobu; Aman, Hiroyuki - In: Applied Financial Economics Letters 4 (2008) 5, pp. 369-373
R&D, particularly basic research, is generally considered as a public good. It provides positive externalities to other firms. This article investigates rival firms' stock-price responses to an increase in the R&D expenditures of a firm. Examining firms in the pharmaceutical industry, we found...